On December 22, Gelonghui Pharmaceutical (002589.SZ) announced that Ruikang Pharmaceutical (002589.SZ) announced that the company's directors, supervisors and senior management team plan to increase their holdings of the company's shares through centralized bidding on the Shenzhen Stock Exchange within 6 months from the date of disclosure of this announcement, with a total increase of not less than RMB 6 million and no more than RMB 10 million.
瑞康医药(002589.SZ)：董事、监事及高管团队拟增持600万元-1000万元公司股份
Ruikang Pharmaceutical (002589.SZ): Directors, supervisors and senior management team plan to increase the company's shares by 6 million yuan to 10 million yuan
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated